Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
| ▸ | ACVR2A | P27037 | 1/20 | 0.31 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24309693 | 1.00 | IRAK4 (0.33) | IRAK4PDGFRBPDGFRALRRK2CHEK1 | |
| SCHEMBL24309788 | 0.84 | GCK (0.36) | CHEK1 | |
| SCHEMBL24309307 | 0.82 | AXL (0.34) | CHEK1CREBBP | |
| SCHEMBL24309828 | 0.81 | AXL (0.33) | — | |
| SCHEMBL24310582 | 0.79 | CYP1A2 (0.34) | — | |
| SCHEMBL24309687 | 0.77 | CDK1 (0.37) | IRAK4PDGFRBPDGFRACREBBP | |
| SCHEMBL26807922 | 0.77 | CDK1 (0.37) | IRAK4PDGFRBPDGFRACREBBP | |
| SCHEMBL29567868 | 0.77 | CDK1 (0.37) | IRAK4PDGFRBPDGFRACREBBP | |
| SCHEMBL24309698 | 0.76 | CDK4 (0.37) | — | |
| SCHEMBL24310334 | 0.73 | WNT1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |